All news
New Hope in Pancreatic Cancer Treatment: Updated Results from the RASolute 302 Trial
23 June 2026Pancreatic cancer remains one of the most challenging cancers to treat. In most cases, it is diagnosed at an advanced stage and is initially treate...
Reflecting on ECCAM 2026: C.O.M.P.A.S. Association Helped Bring Colorectal Cancer Awareness to Thousands Across Romania
23 June 2026Looking back on ECCAM 2026, Romania’s C.O.M.P.A.S. Association helped raise awareness of colorectal cancer through community outreach, patient na...
Munich Awaits: Science, Advocacy and Community in Action
23 June 2026As Europe prepares for the DiCE Masterclass in Munich, discover the latest updates, research advances, community news, and opportunities shaping di...
From Blood Tests to Better Decisions: GUIDE.MRD Advances the Future of Personalised Cancer Care
26 May 2026GUIDE.MRD partners gathered in Switzerland to advance liquid biopsy research in colorectal, pancreatic, and lung cancers. The project aims to detec...
DiCE at the AIDA General Assembly 2026 and AI for Healthcare Event in Genoa
26 May 2026DiCE joined partners in Genoa for the AIDA General Assembly 2026 and the “AI for Healthcare” event, highlighting how artificial intelligence ca...
New Targeted Pill Shows Promise for Advanced Pancreatic Cancer
26 May 2026A new targeted treatment for advanced pancreatic cancer has shown encouraging early results in a major clinical trial. The experimental pill, darax...
Biosimilars, Access, and the Future of Patient Care in Europe
25 May 2026Biosimilars are reshaping conversations around patient access, healthcare sustainability, and resilience across Europe. At the 2026 Biosimilar Medi...
Collaboration Driving Progress: Inside the Latest DISCERN Consortium Meeting
25 May 2026The DISCERN Consortium gathered in Leiden, the Netherlands, for its 4th Annual Meeting, bringing together partners from across Europe to review pro...
POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer
25 May 2026Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...
PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer
25 May 2026The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...